These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Myocardial steatosis, cardiac remodelling and fitness in insulin-sensitive and insulin-resistant obese women. Utz W; Engeli S; Haufe S; Kast P; Hermsdorf M; Wiesner S; Pofahl M; Traber J; Luft FC; Boschmann M; Schulz-Menger J; Jordan J Heart; 2011 Oct; 97(19):1585-9. PubMed ID: 21775510 [TBL] [Abstract][Full Text] [Related]
6. Obesity Cardiomyopathy: Pathophysiologic Factors and Nosologic Reevaluation. Bhatheja S; Panchal HB; Ventura H; Paul TK Am J Med Sci; 2016 Aug; 352(2):219-22. PubMed ID: 27524223 [TBL] [Abstract][Full Text] [Related]
7. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Peterson LR; Herrero P; Schechtman KB; Racette SB; Waggoner AD; Kisrieva-Ware Z; Dence C; Klein S; Marsala J; Meyer T; Gropler RJ Circulation; 2004 May; 109(18):2191-6. PubMed ID: 15123530 [TBL] [Abstract][Full Text] [Related]
8. [Leptin as a mediator between obesity and cardiac dysfunction]. Karbowska J; Kochan Z Postepy Hig Med Dosw (Online); 2012 May; 66():267-74. PubMed ID: 22706112 [TBL] [Abstract][Full Text] [Related]
9. Effects of Obesity on Cardiovascular Hemodynamics, Cardiac Morphology, and Ventricular Function. Alpert MA; Omran J; Bostick BP Curr Obes Rep; 2016 Dec; 5(4):424-434. PubMed ID: 27744513 [TBL] [Abstract][Full Text] [Related]
10. Myocardial insulin resistance and cardiac complications of diabetes. Abel ED Curr Drug Targets Immune Endocr Metabol Disord; 2005 Jun; 5(2):219-26. PubMed ID: 16089356 [TBL] [Abstract][Full Text] [Related]
11. Tipping the balance: the pathophysiology of obesity and type 2 diabetes mellitus. McKenney RL; Short DK Surg Clin North Am; 2011 Dec; 91(6):1139-48, vii. PubMed ID: 22054144 [TBL] [Abstract][Full Text] [Related]
13. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy. Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485 [TBL] [Abstract][Full Text] [Related]
14. Insulin Signaling and Heart Failure. Riehle C; Abel ED Circ Res; 2016 Apr; 118(7):1151-69. PubMed ID: 27034277 [TBL] [Abstract][Full Text] [Related]
15. Myocardial structure, function and ischaemic tolerance in a rodent model of obesity with insulin resistance. Wensley I; Salaveria K; Bulmer AC; Donner DG; du Toit EF Exp Physiol; 2013 Nov; 98(11):1552-64. PubMed ID: 23851919 [TBL] [Abstract][Full Text] [Related]
16. Insulin signaling in the heart. Abel ED Am J Physiol Endocrinol Metab; 2021 Jul; 321(1):E130-E145. PubMed ID: 34056923 [TBL] [Abstract][Full Text] [Related]
17. Relation of reduced preclinical left ventricular diastolic function and cardiac remodeling in overweight youth to insulin resistance and inflammation. Dahiya R; Shultz SP; Dahiya A; Fu J; Flatley C; Duncan D; Cardinal J; Kostner KM; Byrne NM; Hills AP; Harris M; Conwell LS; Leong GM Am J Cardiol; 2015 May; 115(9):1222-8. PubMed ID: 25765589 [TBL] [Abstract][Full Text] [Related]
19. Cardiac adaptations to obesity, diabetes and insulin resistance. Glatz JFC; Dyck JRB; Des Rosiers C Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1905-1907. PubMed ID: 29391209 [No Abstract] [Full Text] [Related]
20. Obesity cardiomyopathy: is it a reality? An ultrasonic tissue characterization study. Di Bello V; Santini F; Di Cori A; Pucci A; Palagi C; Delle Donne MG; Fierabracci P; Marsili A; Talini E; Giannetti M; Biadi O; Balbarini A; Mariani M; Pinchera A J Am Soc Echocardiogr; 2006 Aug; 19(8):1063-71. PubMed ID: 16880104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]